These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27363026)

  • 1. Lung cancer exosomes as drivers of epithelial mesenchymal transition.
    Rahman MA; Barger JF; Lovat F; Gao M; Otterson GA; Nana-Sinkam P
    Oncotarget; 2016 Aug; 7(34):54852-54866. PubMed ID: 27363026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
    Lobb RJ; van Amerongen R; Wiegmans A; Ham S; Larsen JE; Möller A
    Int J Cancer; 2017 Aug; 141(3):614-620. PubMed ID: 28445609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in exosomal miRNA profile upon epithelial-mesenchymal transition in human lung cancer cell lines.
    Tang YT; Huang YY; Li JH; Qin SH; Xu Y; An TX; Liu CC; Wang Q; Zheng L
    BMC Genomics; 2018 Nov; 19(1):802. PubMed ID: 30400814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exosomes in the promotion of epithelial-to-mesenchymal transition and metastasis.
    Visan KS; Lobb RJ; Moller A
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1022-1057. PubMed ID: 32114423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Snail1-dependent cancer-associated fibroblasts induce epithelial-mesenchymal transition in lung cancer cells via exosomes.
    You J; Li M; Cao LM; Gu QH; Deng PB; Tan Y; Hu CP
    QJM; 2019 Aug; 112(8):581-590. PubMed ID: 31106370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
    Jeppesen DK; Nawrocki A; Jensen SG; Thorsen K; Whitehead B; Howard KA; Dyrskjøt L; Ørntoft TF; Larsen MR; Ostenfeld MS
    Proteomics; 2014 Mar; 14(6):699-712. PubMed ID: 24376083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
    Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human NANOS3 gene contributes to lung tumour invasion by inducing epithelial-mesenchymal transition.
    Grelet S; Andries V; Polette M; Gilles C; Staes K; Martin AP; Kileztky C; Terryn C; Dalstein V; Cheng CW; Shen CY; Birembaut P; Van Roy F; Nawrocki-Raby B
    J Pathol; 2015 Sep; 237(1):25-37. PubMed ID: 25904364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the transcription factor twist in phenotype alteration through epithelial-mesenchymal transition in lung cancer cells.
    Nakashima H; Hashimoto N; Aoyama D; Kohnoh T; Sakamoto K; Kusunose M; Imaizumi K; Takeyama Y; Sato M; Kawabe T; Hasegawa Y
    Mol Carcinog; 2012 May; 51(5):400-10. PubMed ID: 21594904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression.
    Greening DW; Gopal SK; Mathias RA; Liu L; Sheng J; Zhu HJ; Simpson RJ
    Semin Cell Dev Biol; 2015 Apr; 40():60-71. PubMed ID: 25721809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition.
    Li N; Gao WJ; Liu NS
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2075-2086. PubMed ID: 28537678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail-induced epithelial-mesenchymal transition in gastric carcinoma cells and generation of cancer stem cell characteristics.
    Yang YJ; Li ZB; Zhang GR; Wu LJ; Yu JY; Hu LJ; Zhou YL; Wang HD; Liang D
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of periostin isoform pattern in non-small cell lung cancer.
    Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
    Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab.
    Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Calderwood SK; Okamoto K; Kozaki KI
    Oral Oncol; 2018 Nov; 86():251-257. PubMed ID: 30409309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
    Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
    Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.
    Raungrut P; Wongkotsila A; Champoochana N; Lirdprapamongkol K; Svasti J; Thongsuksai P
    Anticancer Res; 2018 Jun; 38(6):3507-3514. PubMed ID: 29848704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Tyrosine-Phosphorylated Proteins Upregulated during Epithelial-Mesenchymal Transition Induced with TGF-β.
    Okayama A; Miyagi Y; Oshita F; Ito H; Nakayama H; Nishi M; Kurata Y; Kimura Y; Ryo A; Hirano H
    J Proteome Res; 2015 Oct; 14(10):4127-36. PubMed ID: 26216473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.